Terms: = Liver cancer AND LDH AND Treatment
304 results:
1. [The Value of Baseline PET/CT Imaging of Bone Marrow
Wang Y; Zhao M; Yuan L; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):439-444. PubMed ID: 38660849
[TBL] [Abstract] [Full Text] [Related]
2. Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy.
Shen L; Tan H; Nie J; Jiang Y; Nuerhashi G; Qi H; Cao F; Wen C; Chen S; Zhang T; Zheng W; Liu P; Liu Y; Huang T; Li D; Zhang X; Fan W
Cancer Immunol Immunother; 2024 Mar; 73(4):68. PubMed ID: 38430269
[TBL] [Abstract] [Full Text] [Related]
3. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
[TBL] [Abstract] [Full Text] [Related]
4. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study.
Bektaş M; Işık EG; Oğuz E; Kemik F; Abbasgholizadeh A; İnce B; Özkan ZG; Yalçınkaya Y; Artım-Esen B; Gül A; İnanç M
Clin Exp Rheumatol; 2024 Feb; 42(2):358-366. PubMed ID: 38293968
[TBL] [Abstract] [Full Text] [Related]
5. Calcium-sensing receptor and NF-κB pathways in TN breast cancer contribute to cancer-induced cardiomyocyte damage via activating neutrophil extracellular traps formation.
Zeng J; Cheng Y; Xie W; Lin X; Ding C; Xu H; Cui B; Chen Y; Gao S; Zhang S; Liu K; Lu Y; Zhou J; Shi Z; Sun Y
Cell Mol Life Sci; 2024 Jan; 81(1):19. PubMed ID: 38196005
[TBL] [Abstract] [Full Text] [Related]
6. Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
Wagner NB; Lenders MM; Kühl K; Reinhardt L; Fuchß M; Ring N; Stäger R; Zellweger C; Ebel C; Kimeswenger S; Oellinger A; Amaral T; Forschner A; Leiter U; Klumpp B; Hoetzenecker W; Terheyden P; Mangana J; Loquai C; Cozzio A; Garbe C; Meier F; Eigentler TK; Flatz L
Eur J Cancer; 2024 Jan; 196():113425. PubMed ID: 38039778
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of NF-κB Expression by Thymoquinone; A Role in Regulating Pro-Inflammatory Cytokines and Programmed Cell Death in Hepatic cancer Cells.
Salah A; Sleem R; Abd-Elaziz A; Khalil H
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3739-3748. PubMed ID: 38019231
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Value of Lactate Dehydrogenase in Patients with Melanoma Treated with Pembrolizumab.
Popović A; Petković I; Dimitrijevic A; Jović A
Acta Dermatovenerol Croat; 2023 Nov; 31(2):86-91. PubMed ID: 38006368
[TBL] [Abstract] [Full Text] [Related]
9. Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel.
Jin J; Fan Z; Long Y; Li Y; He Q; Yang Y; Zhong W; Lin D; Lian D; Wang X; Xiao J; Chen Y
Phytomedicine; 2024 Jan; 122():155165. PubMed ID: 37922791
[TBL] [Abstract] [Full Text] [Related]
10. GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.
Lu LL; Xiao SX; Lin ZY; Bai JJ; Li W; Song ZQ; Zhou YH; Lu B; Wu WZ
Cell Biol Toxicol; 2023 Dec; 39(6):3101-3119. PubMed ID: 37853185
[TBL] [Abstract] [Full Text] [Related]
11. Circulating sNinj1 as a novel predictor of prognosis and severity in hepatocellular carcinoma.
Yan L; Su W; Gan D; Li D; Mai L; Wang B; Wang L; Peng L; Jiang L; Wang Z; Hu Q; Chen W
Clin Chim Acta; 2023 Oct; 550():117581. PubMed ID: 37802206
[TBL] [Abstract] [Full Text] [Related]
12. Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma.
Beypınar I; Sözel Y; Önder AH
Cancer Biomark; 2023; 38(3):367-377. PubMed ID: 37718781
[TBL] [Abstract] [Full Text] [Related]
13. Nomogram Based on liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.
Liang L; Li Y; Hong Y; Ji T; Chen H; Lin Z
Curr Oncol; 2023 Jul; 30(8):7189-7202. PubMed ID: 37623002
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study.
Ohba K; Monji K; Osawa T; Yamana K; Yasuda Y; Tanaka H; Nakagawa Y; Fukuyama T; Matsubara N; Uemura H; Sakai H; Eto M
Int J Urol; 2023 Nov; 30(11):977-984. PubMed ID: 37434386
[TBL] [Abstract] [Full Text] [Related]
15. A retrospect study based on real-world data to observe metabolic function in cancer patients using albumin-bound paclitaxel.
Zheng Q; Wang H; Xue C; Yang S; Wang Y; Hou W; Zhang Y
Sci Rep; 2023 Jun; 13(1):9028. PubMed ID: 37270638
[TBL] [Abstract] [Full Text] [Related]
16. Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first-line anti-programmed death-1 monotherapy: A real-world multicentre observational cohort study.
Ochenduszko S; García Sanchez J; Fita MJJ; González-Barrallo I; Herrero Colomina J; Mujika K; Beveridge RD; Martínez SR; Lafuente BS; Tomas AC; Jaime AB; Cerezuela Fuentes P; Fra PL; Peeters AG; Meana García JA; García MAA; Altozano JP; Cancela M; Puchades AM; Roca FF; Maiques IM
Pigment Cell Melanoma Res; 2023 Sep; 36(5):388-398. PubMed ID: 37243929
[TBL] [Abstract] [Full Text] [Related]
17. Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Stukalin I; Navani V; Gupta M; Ruan Y; Boyne DJ; O'Sullivan DE; Meyers DE; Goutam S; Sander M; Ewanchuk BW; Brenner DR; Suo A; Cheung WY; Heng DYC; Monzon JG; Cheng T
Oncologist; 2023 Sep; 28(9):812-822. PubMed ID: 37011230
[TBL] [Abstract] [Full Text] [Related]
18. Some Wild Mushrooms with High Antioxidant Capacity Exhibit Potent Anticancer Activity on cancer Cells using the Apoptotic and Antimigration Cell Death Mechanisms.
Şebin M; Yılmaz N; Aydın A
Anticancer Agents Med Chem; 2023; 23(13):1567-1576. PubMed ID: 37005536
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy.
Yan W; Sun C; Ou X; Hu C
Cancer Imaging; 2023 Feb; 23(1):21. PubMed ID: 36829263
[TBL] [Abstract] [Full Text] [Related]
20. Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.
Salfati D; Huot M; Aparicio T; Lepage C; Taieb J; Bouché O; Boige V; Phelip JM; Dahan L; Bennouna J; Le Malicot K; Boussari O; Gornet JM
Dig Liver Dis; 2023 Jun; 55(6):791-798. PubMed ID: 36725401
[TBL] [Abstract] [Full Text] [Related]
[Next]
